RXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.43%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,847,745.87

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$3.25

▼ -0.12 (-3.56%)

As of 03/20/2026 05:00 PM ET

Days: 30 | 90 | 365

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2026	Ben R Taylor	CFO	Sell	7,956	$3.39	$26,970.84	1,180,318
3/9/2026	Najat Khan	CEO	Sell	28,298	$3.35	$94,798.30	2,262,085
2/18/2026	Ben R Taylor	CFO	Sell	13,426	$3.08	$41,352.08	1,195,349
2/3/2026	Blake Borgeson	Director	Sell	220,000	$4.20	$924,000.00	6,429,863
1/6/2026	Blake Borgeson	Director	Sell	220,000	$4.36	$959,200.00	6,649,863
12/29/2025	Ben R Taylor	CFO	Sell	21,383	$4.18	$89,380.94	761,550
12/22/2025	Najat Khan	Insider	Sell	124,403	$4.41	$548,617.23	611,135
12/2/2025	Blake Borgeson	Director	Sell	220,000	$4.37	$961,400.00	6,869,863
8/18/2025	Najat Khan	Insider	Sell	36,599	$5.52	$202,026.48	668,197
11/13/2024	Michael Secora	CFO	Sell	15,000	$7.66	$114,900.00	1,499,631
11/12/2024	Blake Borgeson	Director	Sell	11,447	$7.64	$87,455.08	7,066,113
10/29/2024	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,077,560
10/24/2024	Tina Marriott	COO	Sell	6,000	$6.31	$37,860.00	521,138
10/15/2024	Blake Borgeson	Director	Sell	11,447	$6.67	$76,351.49	7,089,007
10/8/2024	Michael Secora	CFO	Sell	15,000	$6.32	$94,800.00	1,426,506
10/2/2024	Christopher Gibson	CEO	Sell	20,000	$6.16	$123,200.00	762,656
10/1/2024	Blake Borgeson	Director	Sell	11,447	$6.22	$71,200.34	7,098,428
9/26/2024	Tina Marriott	COO	Sell	6,000	$7.00	$42,000.00	521,138
9/17/2024	Blake Borgeson	Director	Sell	11,447	$6.84	$78,297.48	7,109,875
9/10/2024	Michael Secora	CFO	Sell	15,000	$6.17	$92,550.00	1,377,756
9/4/2024	Christopher Gibson	CEO	Sell	20,000	$6.04	$120,800.00	762,656
9/3/2024	Blake Borgeson	Director	Sell	11,447	$6.27	$71,772.69	7,121,322
8/29/2024	Tina Marriott	COO	Sell	6,000	$7.56	$45,360.00	521,138
8/20/2024	Blake Borgeson	Director	Sell	11,447	$7.12	$81,502.64	7,132,769
8/13/2024	Michael Secora	CFO	Sell	15,000	$6.35	$95,250.00	1,340,968
8/7/2024	Christopher Gibson	CEO	Sell	30,000	$7.10	$213,000.00	758,738
8/6/2024	Blake Borgeson	Director	Sell	11,447	$6.82	$78,068.54	7,144,216
7/25/2024	Tina Marriott	COO	Sell	6,000	$8.13	$48,780.00	535,457
7/23/2024	Blake Borgeson	Director	Sell	11,447	$8.48	$97,070.56	7,155,663
7/10/2024	Christopher Gibson	CEO	Sell	50,000	$7.48	$374,000.00	758,738
7/9/2024	Blake Borgeson	Director	Sell	11,447	$7.32	$83,792.04	7,167,110
7/9/2024	Michael Secora	CFO	Sell	15,000	$7.32	$109,800.00	1,292,218
6/27/2024	Tina Marriott	COO	Sell	6,000	$7.21	$43,260.00	535,457
6/25/2024	Blake Borgeson	Director	Sell	11,447	$9.51	$108,860.97	7,177,116
6/13/2024	Michael Secora	CFO	Sell	15,000	$9.32	$139,800.00	1,243,468
6/11/2024	Blake Borgeson	Director	Sell	11,447	$8.45	$96,727.15	7,188,563
6/5/2024	Christopher Gibson	CEO	Sell	50,000	$8.42	$421,000.00	758,738
5/30/2024	Tina Marriott	COO	Sell	3,000	$8.78	$26,340.00	535,457
5/28/2024	Blake Borgeson	Director	Sell	11,447	$9.17	$104,968.99	7,186,913
5/1/2024	Christopher Gibson	CEO	Sell	50,000	$7.73	$386,500.00	863,524
4/30/2024	Blake Borgeson	Director	Sell	11,447	$7.95	$91,003.65	7,218,414
4/25/2024	Tina Marriott	COO	Sell	3,000	$7.67	$23,010.00	543,231
4/17/2024	Michael Secora	CFO	Sell	23,124	$7.58	$175,279.92	1,231,055
4/16/2024	Blake Borgeson	Director	Sell	11,447	$7.66	$87,684.02	7,229,861
4/3/2024	Christopher Gibson	CEO	Sell	40,000	$8.84	$353,600.00	978,524
4/2/2024	Blake Borgeson	Director	Sell	11,447	$8.82	$100,962.54	7,241,308
3/28/2024	Christopher Gibson	CEO	Sell	40,000	$10.10	$404,000.00	1,043,524
3/21/2024	Tina Marriott	COO	Sell	8,000	$10.75	$86,000.00	639,982
3/19/2024	Blake Borgeson	Director	Sell	20,054	$10.79	$216,382.66	7,252,755
3/13/2024	Michael Secora	CFO	Sell	25,000	$11.03	$275,750.00	1,204,179
3/6/2024	Christopher Gibson	CEO	Sell	36,319	$11.86	$430,743.34	1,108,524
3/5/2024	Blake Borgeson	Director	Sell	20,054	$12.06	$241,851.24	7,272,809
2/22/2024	Tina Marriott	COO	Sell	8,000	$14.89	$119,120.00	639,982
2/20/2024	Blake Borgeson	Director	Sell	20,054	$12.32	$247,065.28	7,292,863
2/13/2024	Michael Secora	CFO	Sell	25,000	$9.86	$246,500.00	1,173,851
2/7/2024	Christopher Gibson	CEO	Sell	48,272	$9.22	$445,067.84	774,703
2/6/2024	Blake Borgeson	Director	Sell	11,447	$9.30	$106,457.10	7,312,917
1/25/2024	Tina Marriott Larson	COO	Sell	8,000	$10.35	$82,800.00	414,548
1/23/2024	Blake Borgeson	Director	Sell	20,054	$10.58	$212,171.32	7,324,364
1/16/2024	Michael Secora	CFO	Sell	25,000	$10.45	$261,250.00	968,514
1/16/2024	Shafique Virani	Insider	Sell	18,000	$10.93	$196,740.00	136,748
1/9/2024	Dean Y. Li	Director	Sell	29,000	$13.66	$396,140.00	421,000
1/3/2024	Christopher Gibson	CEO	Sell	30,853	$9.49	$292,794.97	791,725
12/26/2023	Blake Borgeson	Director	Sell	20,054	$10.63	$213,174.02	7,364,472
12/15/2023	Shafique Virani	Insider	Sell	18,000	$9.60	$172,800.00	136,748
12/14/2023	Zavain Dar	Director	Sell	20,141	$9.00	$181,269.00	53,823
12/12/2023	Blake Borgeson	Director	Sell	11,447	$7.40	$84,707.80	7,384,526
12/12/2023	Michael Secora	CFO	Sell	25,000	$7.39	$184,750.00	943,514
12/6/2023	Christopher Gibson	CEO	Sell	59,829	$7.49	$448,119.21	791,328
11/28/2023	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,395,973
11/16/2023	Tina Marriott Larson	COO	Sell	3,000	$6.76	$20,280.00	413,404
11/15/2023	Shafique Virani	Insider	Sell	18,000	$6.51	$117,180.00	140,351
11/14/2023	Blake Borgeson	Director	Sell	8,885	$6.32	$56,153.20	7,407,420
11/14/2023	Michael Secora	CFO	Sell	25,000	$6.32	$158,000.00	925,686
11/1/2023	Christopher Gibson	CEO	Sell	37,177	$5.20	$193,320.40	836,820
10/31/2023	Blake Borgeson	Director	Sell	8,885	$5.27	$46,823.95	7,416,305
10/26/2023	Tina Marriott Larson	COO	Sell	3,000	$5.63	$16,890.00	418,782
10/17/2023	Blake Borgeson	Director	Sell	8,885	$6.58	$58,463.30	7,425,190
10/16/2023	Shafique Virani	Insider	Sell	18,000	$6.30	$113,400.00	140,351
10/10/2023	Michael Secora	CFO	Sell	25,000	$7.07	$176,750.00	900,686
10/4/2023	Christopher Gibson	CEO	Sell	59,794	$7.21	$431,114.74	842,747
10/3/2023	Blake Borgeson	Director	Sell	8,885	$7.29	$64,771.65	7,434,075
9/28/2023	Tina Marriott Larson	COO	Sell	3,000	$7.72	$23,160.00	418,782
9/19/2023	Blake Borgeson	Director	Sell	8,885	$8.36	$74,278.60	7,442,960
9/15/2023	Shafique Virani	Insider	Sell	18,000	$8.66	$155,880.00	140,351
9/13/2023	Michael Secora	CFO	Sell	25,000	$8.69	$217,250.00	888,186
9/6/2023	Christopher Gibson	CEO	Sell	33,765	$8.78	$296,456.70	871,291
9/5/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,451,845
8/24/2023	Tina Marriott Larson	COO	Sell	3,000	$8.66	$25,980.00	418,782
8/22/2023	Blake Borgeson	Director	Sell	8,885	$8.91	$79,165.35	7,460,730
8/16/2023	Michael Secora	CFO	Sell	25,000	$8.90	$222,500.00	863,186
8/15/2023	Shafique Virani	Insider	Sell	18,000	$9.25	$166,500.00	140,351
8/8/2023	Blake Borgeson	Director	Sell	17,770	$11.16	$198,313.20	7,469,615
8/2/2023	Christopher Gibson	CEO	Sell	65,015	$13.04	$847,795.60	890,719
7/27/2023	Tina Marriott Larson	COO	Sell	8,000	$13.62	$108,960.00	424,160
7/26/2023	Shafique Virani	Insider	Sell	20,000	$14.41	$288,200.00	143,954
7/25/2023	Blake Borgeson	Director	Sell	18,719	$14.61	$273,484.59	7,487,385
7/18/2023	Michael Secora	CFO	Sell	25,000	$13.63	$340,750.00	830,413
7/17/2023	Shafique Virani	Insider	Sell	30,000	$11.72	$351,600.00	143,954
7/13/2023	Terry-Ann Burrell	Director	Sell	8,275	$12.59	$104,182.25	54,847
7/12/2023	Christopher Gibson	CEO	Sell	31,818	$13.14	$418,088.52	915,810
7/11/2023	Blake Borgeson	Director	Sell	8,885	$6.89	$61,217.65	7,520,104
6/29/2023	Tina Marriott Larson	COO	Sell	3,000	$7.49	$22,470.00	424,160
6/27/2023	Blake Borgeson	Director	Sell	8,885	$7.39	$65,660.15	7,528,989
6/13/2023	Blake Borgeson	Director	Sell	15,485	$9.98	$154,540.30	7,525,262
6/13/2023	Michael Secora	CFO	Sell	25,000	$9.93	$248,250.00	805,413
6/7/2023	Christopher Gibson	CEO	Sell	56,436	$9.05	$510,745.80	916,378
6/1/2023	Shafique Virani	Insider	Sell	25,000	$8.58	$214,500.00	161,819
5/31/2023	Tina Marriott Larson	COO	Sell	3,000	$8.63	$25,890.00	424,160
5/30/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,540,747
5/16/2023	Blake Borgeson	Director	Sell	8,885	$5.09	$45,224.65	7,549,632
5/3/2023	Christopher Gibson	CEO	Sell	33,073	$4.71	$155,773.83	953,225
4/18/2023	Blake Borgeson	Director	Sell	8,885	$5.93	$52,688.05	7,558,517
4/5/2023	Christopher Gibson	CEO	Sell	13,327	$6.46	$86,092.42	946,710
4/4/2023	Blake Borgeson	Director	Sell	8,885	$6.53	$58,019.05	7,567,402
3/21/2023	Blake Borgeson	Director	Sell	8,885	$7.40	$65,749.00	7,576,287

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

89.06% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/20/2026	Hsbc Holdings PLC	818,316	$3.37M	0.0%	+537.3%	0.155%
3/17/2026	Rockefeller Capital Management L.P.	34,289	$0.14M	0.0%	-35.8%	0.007%
3/13/2026	Fund Advisors of America Inc FL	20,155	$82K	0.1%	N/A	0.004%
3/9/2026	Corient Private Wealth LLC	17,096	$70K	0.0%	N/A	0.003%
3/6/2026	Hsbc Holdings PLC	818,316	$3.37M	0.0%	+537.3%	0.157%
2/19/2026	Invesco Ltd.	526,144	$2.15M	0.0%	+25.8%	0.101%
2/19/2026	Corient Private Wealth LLC	17,096	$70K	0.0%	N/A	0.003%
2/18/2026	Mercer Global Advisors Inc. ADV	25,020	$100K	0.0%	+55.5%	0.005%
2/18/2026	NewEdge Advisors LLC	33,757	$0.14M	0.0%	+149.5%	0.006%
2/18/2026	XTX Topco Ltd	47,908	$0.20M	0.0%	+104.0%	0.009%
2/18/2026	nVerses Capital LLC	21,564	$88K	0.2%	N/A	0.004%
2/18/2026	VARCOV Co.	128,536	$0.53M	0.2%	N/A	0.025%
2/18/2026	Virtus Investment Advisers LLC	61,439	$0.25M	0.1%	+179.2%	0.012%
2/18/2026	Twinbeech Capital LP	38,352	$0.16M	0.0%	N/A	0.007%
2/18/2026	Quadrature Capital Ltd	142,667	$0.58M	0.0%	-27.2%	0.027%
2/18/2026	Oxford Asset Management LLP	29,509	$0.12M	0.0%	N/A	0.006%
2/18/2026	Millennium Management LLC	1,495,839	$6.12M	0.0%	N/A	0.288%
2/18/2026	Man Group plc	27,960	$0.11M	0.0%	N/A	0.005%
2/18/2026	Balyasny Asset Management L.P.	668,174	$2.73M	0.0%	+18.8%	0.129%
2/17/2026	Guggenheim Capital LLC	183,447	$0.75M	0.0%	+45.6%	0.035%
2/17/2026	Lazard Asset Management LLC	420,006	$1.72M	0.0%	-15.2%	0.081%
2/17/2026	Equitable Holdings Inc.	10,000	$41K	0.0%	-74.6%	0.002%
2/17/2026	RPO LLC	15,120	$62K	0.0%	N/A	0.003%
2/17/2026	Jump Financial LLC	661,629	$2.71M	0.0%	+19.2%	0.127%
2/17/2026	Price T Rowe Associates Inc. MD	415,363	$1.70M	0.0%	+30.3%	0.080%
2/17/2026	Osaic Holdings Inc.	116,966	$0.48M	0.0%	-53.9%	0.023%
2/17/2026	California State Teachers Retirement System	350,305	$1.43M	0.0%	+5.4%	0.067%
2/17/2026	Softbank Group CORP.	13,636,515	$55.77M	0.4%	-7.0%	2.623%
2/17/2026	Russell Investments Group Ltd.	73,273	$0.30M	0.0%	+52.5%	0.014%
2/17/2026	Atom Investors LP	94,287	$0.39M	0.0%	N/A	0.018%
2/17/2026	State of Wisconsin Investment Board	167,874	$0.69M	0.0%	-5.9%	0.032%
2/17/2026	Captrust Financial Advisors	17,108	$70K	0.0%	N/A	0.003%
2/17/2026	ExodusPoint Capital Management LP	391,801	$1.60M	0.0%	+90.9%	0.075%
2/17/2026	Royal Bank of Canada	99,759	$0.41M	0.0%	+46.3%	0.019%
2/17/2026	Blair William & Co. IL	74,000	$0.30M	0.0%	-3.9%	0.014%
2/16/2026	Squarepoint Ops LLC	887,004	$3.63M	0.0%	N/A	0.171%
2/16/2026	Barclays PLC	1,469,262	$6.01M	0.0%	-5.2%	0.283%
2/13/2026	Arete Wealth Advisors LLC	25,500	$0.10M	0.0%	-35.5%	0.005%
2/13/2026	Marshall Wace LLP	226,609	$0.93M	0.0%	+189.6%	0.044%
2/13/2026	The Manufacturers Life Insurance Company	204,949	$0.84M	0.0%	+9.9%	0.039%
2/13/2026	Stifel Financial Corp	590,148	$2.41M	0.0%	+33.3%	0.114%
2/13/2026	Hudson Bay Capital Management LP	425,000	$1.74M	0.0%	+88.9%	0.082%
2/13/2026	Carroll Investors Inc	404,936	$1.66M	0.8%	+2.1%	0.078%
2/13/2026	Rafferty Asset Management LLC	968,814	$3.96M	0.0%	+29.1%	0.186%
2/13/2026	Arkadios Wealth Advisors	38,840	$0.16M	0.0%	-14.5%	0.007%
2/13/2026	First Trust Advisors LP	2,266,691	$9.27M	0.0%	+26.1%	0.436%
2/13/2026	Headlands Technologies LLC	231,472	$0.95M	0.1%	+22.4%	0.045%
2/13/2026	Ausdal Financial Partners Inc.	10,000	$41K	0.0%	-45.9%	0.002%
2/13/2026	Charles Schwab Investment Management Inc.	3,994,651	$16.34M	0.0%	+16.0%	0.768%
2/13/2026	State Street Corp	25,333,888	$103.62M	0.0%	+38.7%	4.873%
2/13/2026	Ieq Capital LLC	40,048	$0.16M	0.0%	+17.6%	0.008%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	4,075,219	$16.67M	0.0%	-2.9%	0.784%
2/13/2026	Wells Fargo & Company MN	1,160,990	$4.75M	0.0%	+44.9%	0.223%
2/12/2026	HRT Financial LP	256,571	$1.05M	0.0%	N/A	0.049%
2/12/2026	MetLife Investment Management LLC	209,801	$0.86M	0.0%	-2.5%	0.040%
2/12/2026	Cibc World Markets Corp	25,169	$0.10M	0.0%	N/A	0.005%
2/12/2026	Commonwealth Equity Services LLC	85,343	$0.35M	0.0%	+85.4%	0.016%
2/12/2026	Dimensional Fund Advisors LP	30,060	$0.12M	0.0%	N/A	0.006%
2/12/2026	Ensign Peak Advisors Inc	29,264	$0.12M	0.0%	-92.9%	0.006%
2/12/2026	IQ EQ FUND MANAGEMENT IRELAND Ltd	2,404,118	$9.83M	0.7%	+35.4%	0.462%
2/12/2026	Steward Partners Investment Advisory LLC	39,364	$0.16M	0.0%	-26.9%	0.008%
2/12/2026	Bank of Montreal Can	27,782	$0.11M	0.0%	+34.9%	0.005%
2/12/2026	Raiffeisen Bank International AG	150,000	$0.62M	0.0%	+7.1%	0.029%
2/12/2026	Swiss National Bank	720,300	$2.95M	0.0%	+16.1%	0.139%
2/12/2026	Resurgent Financial Advisors LLC	20,300	$83K	0.0%	N/A	0.004%
2/12/2026	Nuveen LLC	1,084,925	$4.44M	0.0%	-15.0%	0.209%
2/11/2026	ARK Investment Management LLC	37,316,856	$152.63M	1.0%	+11.2%	7.179%
2/11/2026	Deutsche Bank AG	297,504	$1.22M	0.0%	+10.4%	0.057%
2/11/2026	Amova Asset Management Americas Inc.	6,221,025	$25.38M	0.3%	-16.7%	1.197%
2/11/2026	Cerity Partners LLC	70,281	$0.29M	0.0%	+14.2%	0.014%
2/11/2026	LPL Financial LLC	433,132	$1.77M	0.0%	+8.5%	0.083%
2/11/2026	Franklin Resources Inc.	30,391	$0.12M	0.0%	-68.4%	0.006%
2/11/2026	JPMorgan Chase & Co.	1,278,944	$5.23M	0.0%	+204.8%	0.246%
2/11/2026	Los Angeles Capital Management LLC	43,511	$0.18M	0.0%	N/A	0.008%
2/11/2026	Tradition Wealth Management LLC	66,413	$0.27M	0.0%	+63.1%	0.013%
2/10/2026	Cibc World Market Inc.	37,948	$0.16M	0.0%	-32.9%	0.007%
2/10/2026	WCG Wealth Advisors LLC	60,465	$0.25M	0.0%	N/A	0.012%
2/10/2026	CIBC Asset Management Inc	15,865	$65K	0.0%	N/A	0.003%
2/10/2026	Goldman Sachs Group Inc.	2,201,442	$9M	0.0%	+74.5%	0.423%
2/10/2026	Lingotto Investment Management LLP	4,931,057	$20.17M	0.4%	+34.2%	0.949%
2/10/2026	Essex Financial Services Inc.	14,942	$61K	0.0%	-48.7%	0.003%
2/10/2026	BNP Paribas Financial Markets	1,084,198	$4.43M	0.0%	+858.4%	0.209%
2/10/2026	Norges Bank	5,739,064	$23.47M	0.0%	N/A	1.104%
2/10/2026	Eurizon Capital SGR S.p.A.	95,194	$0.39M	0.0%	N/A	0.018%
2/10/2026	Intech Investment Management LLC	155,334	$0.64M	0.0%	-2.5%	0.030%
2/9/2026	Kingsview Wealth Management LLC	12,314	$50K	0.0%	-62.2%	0.002%
2/9/2026	Geode Capital Management LLC	10,934,252	$44.73M	0.0%	+13.6%	2.103%
2/9/2026	King Luther Capital Management Corp	20,000	$82K	0.0%	-22.4%	0.004%
2/9/2026	Powell Investment Advisors LLC	29,696	$0.12M	0.0%	+155.8%	0.006%
2/9/2026	Prospera Financial Services Inc	15,589	$64K	0.0%	N/A	0.003%
2/6/2026	Leonteq Securities AG	124,629	$0.51M	0.0%	N/A	0.024%
2/6/2026	IFP Advisors Inc	30,355	$0.12M	0.0%	+193.1%	0.006%
2/6/2026	Handelsbanken Fonder AB	108,900	$0.45M	0.0%	+22.8%	0.021%
2/6/2026	Profund Advisors LLC	356,662	$1.46M	0.0%	+120.9%	0.069%
2/6/2026	ProShare Advisors LLC	92,242	$0.38M	0.0%	+18.4%	0.018%
2/6/2026	HighTower Advisors LLC	26,028	$0.11M	0.0%	-45.5%	0.005%
2/5/2026	Abacus Wealth Partners LLC	13,778	$56K	0.0%	N/A	0.003%
2/5/2026	Plancorp LLC	84,500	$0.35M	0.0%	-5.6%	0.016%
2/4/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	29,200	$0.12M	0.0%	N/A	0.006%
2/4/2026	Pier 88 Investment Partners LLC	97,140	$0.40M	0.1%	-18.1%	0.019%

Data available starting January 2016

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $3.25

$3.21

$3.42

50 Day Range

MA: $3.90

$3.25

$4.96

52 Week Range

Now: $3.25

$2.98

$7.18

Volume

26,798,514 shs

Average Volume

15,966,794 shs

Market Capitalization

$1.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Blake Borgeson (Director)
Najat Khan (CEO)
Michael Secora (CFO)
Ben R Taylor (CFO)
Christopher Gibson (CEO)
Najat Khan (Insider)
Tina Marriott (COO)
Learn More about top insider investors at Recursion Pharmaceuticals.
Who are the major institutional investors of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.08%
ARK Investment Management LLC — 7.18%
State Street Corp — 4.87%
Baillie Gifford & Co. — 4.57%
Softbank Group CORP. — 2.62%
Geode Capital Management LLC — 2.10%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.
Which institutional investors are selling Recursion Pharmaceuticals stock?: Within the previous quarter, RXRX stock was sold by these institutional investors:
Sumitomo Mitsui Trust Group Inc.
Amova Asset Management Americas Inc.
Softbank Group CORP.
Ensign Peak Advisors Inc
Baillie Gifford & Co.
Nuveen LLC
IMC Chicago LLC
Simplex Trading LLC
During the last year, company insiders that have sold Recursion Pharmaceuticals company stock include:
Blake Borgeson (Director)
Najat Khan (CEO)
Michael Secora (CFO)
Ben R Taylor (CFO)
Learn More investors selling Recursion Pharmaceuticals stock.
Which institutional investors are buying Recursion Pharmaceuticals stock?: In the previous quarter, RXRX stock was purchased by institutional investors including:
Vanguard Group Inc.
State Street Corp
Norges Bank
ARK Investment Management LLC
Millennium Management LLC
Geode Capital Management LLC
Lingotto Investment Management LLP
BNP Paribas Financial Markets